168 related articles for article (PubMed ID: 14595703)
1. Pharmacokinetics and tissue distribution of uraemic indoxyl sulphate in rats.
Deguchi T; Nakamura M; Tsutsumi Y; Suenaga A; Otagiri M
Biopharm Drug Dispos; 2003 Nov; 24(8):345-55. PubMed ID: 14595703
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of indoxyl sulfate in OAT1/3-positive tubular cells in kidneys of patients with chronic renal failure.
Taki K; Nakamura S; Miglinas M; Enomoto A; Niwa T
J Ren Nutr; 2006 Jul; 16(3):199-203. PubMed ID: 16825019
[TBL] [Abstract][Full Text] [Related]
3. Oral sorbent AST-120 increases renal NO synthesis in uremic rats.
Tumur Z; Niwa T
J Ren Nutr; 2008 Jan; 18(1):60-4. PubMed ID: 18089446
[TBL] [Abstract][Full Text] [Related]
4. Renal clearance of endogenous hippurate correlates with expression levels of renal organic anion transporters in uremic rats.
Deguchi T; Takemoto M; Uehara N; Lindup WE; Suenaga A; Otagiri M
J Pharmacol Exp Ther; 2005 Aug; 314(2):932-8. PubMed ID: 15879000
[TBL] [Abstract][Full Text] [Related]
5. Major role of organic anion transporter 3 in the transport of indoxyl sulfate in the kidney.
Deguchi T; Ohtsuki S; Otagiri M; Takanaga H; Asaba H; Mori S; Terasaki T
Kidney Int; 2002 May; 61(5):1760-8. PubMed ID: 11967025
[TBL] [Abstract][Full Text] [Related]
6. An oral sorbent reduces overload of indoxyl sulphate and gene expression of TGF-beta1 in uraemic rat kidneys.
Miyazaki T; Aoyama I; Ise M; Seo H; Niwa T
Nephrol Dial Transplant; 2000 Nov; 15(11):1773-81. PubMed ID: 11071964
[TBL] [Abstract][Full Text] [Related]
7. In vivo kinetics of indoxyl sulfate in humans and its renal interaction with angiotensin-converting enzyme inhibitor quinapril in rats.
Fujita T; Ishihara K; Yasuda S; Nakamura T; Maeda M; Kobayashi M; Sahashi K; Ikeda Y; Kumagai Y; Majima M
J Pharmacol Exp Ther; 2012 Jun; 341(3):626-33. PubMed ID: 22389425
[TBL] [Abstract][Full Text] [Related]
8. Possible involvement of nuclear factor-kappaB inhibition in the renal protective effect of oral adsorbent AST-120 in a rat model of chronic renal failure.
Komiya T; Miura K; Tsukamoto J; Okamura M; Tamada S; Asai T; Tashiro K; Kuwabara N; Iwao H; Yoshikawa J
Int J Mol Med; 2004 Jan; 13(1):133-8. PubMed ID: 14654984
[TBL] [Abstract][Full Text] [Related]
9. Indoxyl sulfate reduces superoxide scavenging activity in the kidneys of normal and uremic rats.
Owada S; Goto S; Bannai K; Hayashi H; Nishijima F; Niwa T
Am J Nephrol; 2008; 28(3):446-54. PubMed ID: 18160814
[TBL] [Abstract][Full Text] [Related]
10. Indoxyl sulfate, a uremic toxin, is biotransformed from indoxyl-beta-D-glucoside (indican) in rats.
Hou YC; Tsai SY; Chan SL; Yang SY; Chao PD
Toxicon; 2008 Sep; 52(3):440-4. PubMed ID: 18619995
[TBL] [Abstract][Full Text] [Related]
11. Uraemic toxins induce proximal tubular injury via organic anion transporter 1-mediated uptake.
Motojima M; Hosokawa A; Yamato H; Muraki T; Yoshioka T
Br J Pharmacol; 2002 Jan; 135(2):555-63. PubMed ID: 11815391
[TBL] [Abstract][Full Text] [Related]
12. Renal organic acid transport: uptake by rat kidney slices of a furan dicarboxylic acid which inhibits plasma protein binding of acidic ligands in uremia.
Henderson SJ; Lindup WE
J Pharmacol Exp Ther; 1992 Oct; 263(1):54-60. PubMed ID: 1403803
[TBL] [Abstract][Full Text] [Related]
13. Stat3 contributes to indoxyl sulfate-induced inflammatory and fibrotic gene expression and cellular senescence.
Shimizu H; Yisireyili M; Nishijima F; Niwa T
Am J Nephrol; 2012; 36(2):184-9. PubMed ID: 22889746
[TBL] [Abstract][Full Text] [Related]
14. Indoxyl-beta-D-glucuronide and 3-indoxyl sulfate in plasma of hemodialysis patients.
Agatsuma S; Sekino H; Watanabe H
Clin Nephrol; 1996 Apr; 45(4):250-6. PubMed ID: 8861801
[TBL] [Abstract][Full Text] [Related]
15. Differences in the pharmacokinetics of 4-amino-3-chlorophenyl hydrogen sulfate, a metabolite of resatorvid, in rats and dogs.
Jinno F; Takeuchi T; Tagawa Y; Kondo T; Itoh T; Asahi S
Drug Metab Dispos; 2012 Apr; 40(4):648-54. PubMed ID: 22203697
[TBL] [Abstract][Full Text] [Related]
16. Expression of kisspeptins and kisspeptin receptor in the kidney of chronic renal failure rats.
Shoji I; Hirose T; Mori N; Hiraishi K; Kato I; Shibasaki A; Yamamoto H; Ohba K; Kaneko K; Morimoto R; Satoh F; Kohzuki M; Totsune K; Takahashi K
Peptides; 2010 Oct; 31(10):1920-5. PubMed ID: 20621140
[TBL] [Abstract][Full Text] [Related]
17. The protein metabolite hypothesis, a model for the progression of renal failure: an oral adsorbent lowers indoxyl sulfate levels in undialyzed uremic patients.
Niwa T; Nomura T; Sugiyama S; Miyazaki T; Tsukushi S; Tsutsui S
Kidney Int Suppl; 1997 Nov; 62():S23-8. PubMed ID: 9350673
[TBL] [Abstract][Full Text] [Related]
18. Role of blood-brain barrier organic anion transporter 3 (OAT3) in the efflux of indoxyl sulfate, a uremic toxin: its involvement in neurotransmitter metabolite clearance from the brain.
Ohtsuki S; Asaba H; Takanaga H; Deguchi T; Hosoya K; Otagiri M; Terasaki T
J Neurochem; 2002 Oct; 83(1):57-66. PubMed ID: 12358729
[TBL] [Abstract][Full Text] [Related]
19. Administration of oral charcoal adsorbent (AST-120) suppresses low-turnover bone progression in uraemic rats.
Iwasaki Y; Yamato H; Nii-Kono T; Fujieda A; Uchida M; Hosokawa A; Motojima M; Fukagawa M
Nephrol Dial Transplant; 2006 Oct; 21(10):2768-74. PubMed ID: 16820376
[TBL] [Abstract][Full Text] [Related]
20. Renal disposition of a furan dicarboxylic acid and other uremic toxins in the rat.
Tsutsumi Y; Deguchi T; Takano M; Takadate A; Lindup WE; Otagiri M
J Pharmacol Exp Ther; 2002 Nov; 303(2):880-7. PubMed ID: 12388676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
